|
 |
| lung/nsc |
Werner-Wasik, M., Swann, S., Curran Jr, W., Robert, F., Komaki, R., Lee, C., Jafar, S., Share, R., Choy, H. and Blumenschein, G.: A Phase II Study of Cetuximab (C225) In Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 654s, Abs. #7135, 2005. |
0324 |
biologic/C225 |
 |
| lung/nsc |
Bradley, J., Graham, M., Swann, S., Byhardt, R., Govindan, R., Fowler, J., Purdy, J., Michalski, J., Gore, E. and Choy, H.: Phase I Results of RTOG L-0117; A Phase I/II Dose Intensification Study Using 3DCRT and Concurrent Chemotherapy for Patients with Inoperable NSCLC. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 636s, Abs. #7063, 2005. |
0117 |
RT/3D |
|
| lung/nsc |
Swann, S., Machtay, M., Komaki, R., Langer, C., Sause, W., Langer, C., Byhardt, R. and Curran Jr, W.: Impact of Overall Treatment Time During Concurrent Chemoradiotherapy for Locally Advanced NSCLC: An RTOG Secondary Analysis. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 635s, Abs. #7061, 2005. |
9106, 9204, 9410 |
RT/3D |
|
| lung/nsc |
Albain, K. S., Swann, S., Rusch, V., Turrisi, A. T., Shepherd, F., Smith, C., Gandara, D., Johnson, D., Green, M. and Miller, R.: Phase III Study Of Concurrent Chemotherapy And Radiotherapy (CT/RT) Vs CT/RT Followed By Surgical Resection For Stage IIIA(Pn2) Non-Small Cell Lung Cancer (NSCLC): Outcomes Update Of North American Intergroup 0139 (RTOG 9309). Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 624s, Abs. #7014, 2005. |
9309 |
surg |
|
| lung/nsc |
Choy, H., Swann, S., Walter, C., Whipple, G., Demas, W. and Ettinger, D.: A Phase I trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG Study. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 646s, Abs. #7103, 2005. |
0017 |
chemo/rt |
|
| lung/nsc |
Langer, C., Swann, S., Wasik-Werner, M., Lillenbaum, R., Curran, W., Sandler, A., Scidmore, N. C., Choy, H. and Samuels, M.: Phase I Study of Combination Irinotecan and Cisplatin and Either Twice Daily Thoracic Radiation (45Gy) or Once Daily Thoracic Radiotherapy (70Gy) in Patients with Limited Small Cell Lung Carcinoma (SCLC): Early Toxicity Analysis of RTOG 0241. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S323, Abs. #P-777, 2005. |
0241 |
chemo |
|
| lung/nsc |
Machtay, M., Swann, S., Komaki, R., Byhardt, R., Paulus, R., Sause, W., Curran Jr, W., Albain, K. S. and Movsas, B.: What is the Meaning of Local-Regional Control after Chemoradiation for Locally Advanced NSCLC? An RTOG Analysis. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S17, Abs. #O-041, 2005. |
8808,9015,9106,9204,9309,9410,9801 |
chemo/rt |
|
| lung/nsc |
Werner-Wasik, M., Swann, S., Bradley, J., Graham, M., Emami, B., Purdy, J. and Sause, W.: Increasing Tumor Volume is Predictive of Poor Overall- and Progression Free Survival: Secondary Analysis of the Radiation Therapy Oncology Group (RTOG) 93-11 Phase I-II Radiation Dose Escalation Study in Patients with Inoperable Non-Small Cell Lung Cancer (NSCLC). International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S103, Abs. #PD-121, 2005. |
9311 |
RT/3D |
|
| lung/nsc |
Blumenschein, G., Swann, S., Curran Jr, W., Robert, F., Werner-Wasik, M., Lee, C., Jafar, S., Share, R., Choy, H. and Komaki, R.: A Phase II Study of Cetuximab (C225) In Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S78, Abs. #PD-039, 2005. |
0324 |
biologic/C225 |
|
| lung/nsc |
Bradley, J., Graham, M., Swann, S., Byhardt, R., Govindan, R., Fowler, J., Purdy, J., Michalski, J., Gore, E. and Choy, H.: Phase I Results of RTOG L-0117; a Phase I/II Dose Intensification Study Using 3DCRT and Concurrent Chemotherapy for Patients with Inoperable NSCLC. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S277, Abs. #P-603, 2005. |
0117 |
lung/nsc |
|
| lung/nsc |
Swann, S., Choy, H., Curran, W., Whipple, G., Demas, W. and Ettinger, D.: A Phase I trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy followed by consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG Study. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S270-S271, Abs. #P-578, 2005. |
0017 |
chemo/rt |
|
| lung/nsc |
Rusch, V., Albain, K. S., Turrisi, A. T., Swann, S., Shepherd, F., Chen, Y., Livingston, R., Darling, G., Cox, J. and Sause, W.: Phase III Trial of Concurrent Chemotherapy and Radiotherapy (CT/RT) vs CT/RT Followed by Surgical Resection for Stage IIIa(pN2)Non-Small Cell Lung Cancer (NSCLC): Outcomes and Implications for Surgical Management in North American Intergroup 0139 (RTOG 9309). International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S15, Abs. #O-035, 2005. |
9309 |
surg |
|
| lung/nsc |
Machtay, M., Swann, S., Komaki, R., Sause, W., Langer, C., Byhardt, R. and Curran, W.: Overall Treatment Time During Concurrent Chemoradiotherapy and Outcomes: An RTOG Secondary Analysis. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S17, Abs. #O-042, 2005. |
9106, 9204, 9410 |
chemo/rt |
|
| lung/nsc |
Sun, A., Bezjak, A., Payne, D., Kane, G., Waldron, J., Cho, J., Shepherd, F., Keshavjee, S., Gore, E. and Choy, H.: Prophylactic Cranial Irradiation (PCI) in Locally Advanced Non-Small Cell Lung Cancer (RTOG 0214): How to Improve Accrual to an Important Prospective Randomized Study. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S270, Abs. #P-577, 2005. |
0214 |
chemo/rt |
|
| lung/nsc |
Komaki, R., Swann, S., Byhardt, R. W., Cox, J., Taylor, S., Muammer, T. and Sause, W. T.: Does response rate in the induction chemotherapy predict survival for locally advanced non-small cell lung cancer (LANSCLC)? : Secondary analysis of RTOG 8804/8808. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S88-S89, Abs. #PD-074, 2005. |
8804, 8808 |
chemo/td |
|
| lung/nsc |
Karp, D. D., Lee, S., Keller, S., Johnson, D., Kucuk, O., Clamon, G., Marks, R., Johnston, M., Okawara, G. and Ruckdeschel, J.: Interim Report: A Phase III Randomized Double Blind Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non-Small Cell Lung Cancer. International Assoc Study of Lung Cancer (IASLC), Barcelona, Spain, Lung Cancer, [49] ((Suppl 2)) pg. S181, Abs. #P-252, 2005. |
0127 |
chemo |
|
| lung/nsc |
Langer, C., Swann, S., Curran Jr, W., Movsas, B., Werner-Wasik, M., Komaki, R., Lee, J. S. and Choy, H.: Reassessing Prognostic Factors in the Era of Combined Modality Therapy for Locally Advanced NSCLC: A Retrospective Analysis of RTOG 9410 and 9801. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S39-S40, Abs. #65, 2005. |
9410, 9801 |
chemo |
|
| lung/nsc |
Komaki, R., Swann, S., Curran Jr, W., Robert, F., Werner-Wasik, M., Lee, C., Jafar, S., Share, R., Choy, H. and Blumenschein, G.: A Phase II Study of Cetuximab (C225) in Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S44, Abs. #72, 2005. |
0324 |
biologic/C225 |
|
| lung/nsc |
Movsas, B., Moughan, J., Swann, S., Coyne, J., Konski, A., Komaki, R., Bradley, J., Langer, C., Choy, H. and Watkins Bruner, D.: Back to B.E.D. Predictors of Outcome in RTOG Non-Operative Non-Small Cell Lung Cancer (NSCLC) Trials. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S230-S231, Abs. #1139, 2005. |
multi |
chemo |
|
| lung/nsc |
Choy, H., Swann, S., Curran, W., Whipple, G., Demas, W. and Ettinger, D.: A Phase I Trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG 0017 Study. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S42-S43, Abs. #70, 2005. |
0017 |
chemo |
|
| lung/nsc |
Bradley, J., Deasy, J., Naqa, I. E., Lindsay, P., Hope, A., Bosch, W., Matthews, J., Sause, W. and Graham, M.: Predictors of Lung Toxicity from the RTOG 9311 Radiation Dose Escalation Trial: GTV Position is Important. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S40-S41, Abs. #67, 2005. |
9311 |
RT/3D |
|
| lung/nsc |
Machtay, M., Swann, S., Komaki, R., Byhardt, R., Paulus, R., Sause, W., Albain, K. S., Movsas, B. and Curran Jr, W.: Higher BED is Associated with Improved Local-regional Control and Survival for NSCLC Treated with Chemoradiotherapy: An RTOG Analysis. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S40, Abs. #66, 2005. |
8808,9015,9106,9204,9309,9410,9801 |
chemo |
|
| lung/nsc |
Machtay, M., Hsu, C., Komaki, R., Sause, W., Swann, S., Langer, C., Byhardt, R. and Curran, W.: Effect of Overall Treatment Time on Outcomes After Concurrent Chemoradiation for Locally Advanced Non-Small-Cell Lung Carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) Experience. Int J Radiat Onco Biol Phys, 63 (3):667-671, 2005. |
9106, 9204, 9410 |
chemo |
|
| lung/nsc |
Bradley, J., Paulus, R., Graham, M., Ettinger, D., Johnstone, D., Pilepich, M., Machtay, M., Komaki, R., Atkins, J. and Curran, W.: Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non-Small-Cell Lung Cancer: Promising Long-Term Results of the Radiation Therapy Oncology Group-RTOG 9705. J Clin Oncol, 23 (15):3480-3487, 2005. |
9705 |
surg |
|
| lung/nsc |
Komaki, R., Swann, S., Ettinger, D., Glisson, B., Sandler, A., Movsas, B., Suh, J. and Byhardt, R.: Phase I Study of Thoracic Radiation Dose Escalation with Concurrent Chemotherapy for Patients with Limited Small-Cell Lung Cancer: Report of Radiation Therapy Oncology Group (RTOG) Protocol 97-12. Int J Radiat Onco Biol Phys, 62 (2):342-350, 2005. |
9712 |
chemo |
|
| lung/nsc |
Movsas, B., Scott, C., Langer, C., Werner-Wasik, M., Nicolaou, N., Komaki, R., Machtay, M., Smith, C., Axelrod, R., Sarna, L., Wasserman, T. and Byhardt, R.: Randomized Trial of Amifostine in Locally Advanced Non-Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01. J Clin Oncol, 23 (10):2145-2154, 2005. |
9801 |
protect |
|
| lung/nsc |
Ettinger, D., Berkey, B., Abrams, R., Fontanesi, J., Machtay, M., Duncan, P. J., Curran, W., Movsas, B. and Byhardt, R.: Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study. J Clin Oncol, 23 (22):1-8, 2005. |
9609 |
chemo |
|
| lung/nsc |
Wakelee, H., Stephenson, P., Keller, S., Wagner, H., Herskovic , A., Komaki, R., Marks, R., Perry, M., Livingston, R. and Johnson, D.: Post-Operative Radiotherapy (PORT) or Chemoradiotherapy (CPORT) Following Resection of Stages II and IIIA Non-Small Cell Lung Cancer (NSCLC) Does Not Increase the Expected Risk of Death from Intercurrent Disease (DID) in Eastern Cooperative Oncology Group (ECOG) Trial E3590. Lung Cancer, 48 (3):389-397, 2005. |
9105 |
surg |
|
| lung/nsc |
Komaki, R.: What Should the Optimal Timing Be for Amifostine Administration Relative to Radiation and Chemotherapy? J Clin Oncol, 7232-a-7233, 2005. |
9801 |
none |
|
| lung/nsc |
Bradley, J., Graham, M., Winter, K., Purdy, J., Komaki, R., Roa, W., Ryu, J., Bosch, W. and Emami, B.: Toxicity and Outcome Results of RTOG 9311; a Phase I/II Dose Escalation Study using Three-Dimensional Conformal Radiotherapy in Patients with Inoperable Non-Small Cell Lung Carcinoma. Int J Radiat Onco Biol Phys, 61 (2):318-328, 2005. |
9311 |
RT/3D |
|
| lung/nsc |
Langer, C.: Emerging Role of Epidermal Growth Factor Receptor Inhibition in Therapy for Advanced Malignancy: Focus on NSCLC. Int J Radiat Onco Biol Phys, 58 (3):991-1002, 2004. |
|
EGFR |
|
| LUNG/nsc |
Journal Article Keller, S., Vangel, M., Wagner, H., Schiller, J., Herskovic , A., Komaki, R., Gray, R., Marks, R., Perry, M., Livingston, R. and Johnson, D.: Second Primary Tumors Following Adjuvant Therapy of Resected Stages II and IIIa Non-Small Cell Lung Cancer. Lung Cancer, 42 (1):79-86, 2003. |
9105 |
surg |
|
| LUNG/nsc |
Strauss, G., Herndon II, J. E., Maddaus, M., Johnstone, D., Johnson, E., Watson, D., Sugarbaker, D., Schilsky, R. and Green, M.: Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) Abs. #7019, 2004. |
9616 |
chemo |
|
| LUNG/sc |
Langer, C.: Emerging Role of Epidermal Growth Factor Receptor Inhibition in Therapy for Advanced Malignancy: Focus on NSCLC. Int J Radiat Onco Biol Phys, 58 (3):991-1002, 2004. |
|
EGFR |
|
| LUNG/sc |
Conference Proceedings Komaki, R., Swann, S., Ettinger, D., Glisson, B., Sandler, A., Movsas, B. and Byhardt, R.: Phase I Dose-Escalation Study of Thoracic Irradiation with Concurrent Chemotherapy for Patients with Limited Small Cell Lung Cancer (LSCLC). Radiation Therapy Oncology Group RTOG. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S139, Abs. #25, 2003. |
9712 |
lung/sc
chemo |
|
| LUNG/nsc |
Bradley, J., Graham, M., Winter, K., Purdy, J., Komaki, R., Roa, W., Ryu, J., Bosch, W. and Emami, B.: Acute and Late Toxicity Results of RTOG 9311: A Dose Escalation Study Using 3D Conformal Radiation Therapy in Patients with Inoperable Non-Small Cell Lung Cancer. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S137, Abs. #23, 2003. |
9311 |
lung/nsc
3D |
|
| LUNG/nsc |
Werner-Wasik, M., Scott, C., Movsas, B., Langer, C., Sarna, L., Nicolaou, N., Komaki, R., Machtay, M., Smith, C., Axelrod, R. and Byhardt, R.: Amifostine As Mucosal Protectant in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Intensive Chemotherapy and Thoracic Radiotherapy (RT): Results of the Radiation Therapy Oncology Group (RTOG) 98-01 Study. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S216, Abs. #152, 2003. |
9801 |
lung/nsc
protect |
|
| LUNG/nsc |
Turrisi, A. T., Scott, C., Rusch, V., Albain, K. S., Shepherd, F., Smith, C., Chen, Y., Livingston, R., Gandara, D., Darling, G., Johnson, D. and Green, M.: Randomized Trial of Chemoradiotherapy to 61 Gy [no S] Versus Chemoradiotherapy to 45 Gy Followed by Surgery [S] Using Cisplatin Etoposide in Stage IIIa Non-Small Cell Lung Cancer (NSCLC): Intergroup Trial 0139, RTOG (9309). Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S125-126, Abs. #4, 2003. |
9309 |
lung/nsc
surg |
|
| LUNG/nsc |
Graham, M., Paulus, R., Ettinger, D., Bradley, J., Pilepich, M., Machtay, M., Komaki, R., Atkins, J. and Curran Jr, W.: RTOG 9705, A Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIA Non-Small Cell Lung Cancer (NSCLC) Patients - Promising Long Term Survival Results. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S140-141, Abs. #28, 2003. |
9705 |
lung/nsc
chemo |
|
| LUNG/sc |
Komaki, R., Swann, S., Ettinger, D., Glisson, B., Sandler, A., Movsas, B. and Byhardt, R.: Phase I Dose-Escalation Study of Thoracic Irradiation with Concurrent Chemotherapy for Patients with Limited Small Cell Lung Cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) Protocol 97-12. International Assoc Study of Lung Cancer (IASLC), Vancouver, British Columbia, Lung Cancer Meeting Booklet, pg. S104, Abs. #P-53, 2003. |
9712 |
lung/sc
chemo |
|
| LUNG/nsc |
Albain, K. S., Scott, C., Rusch, V., Turrisi, A. T., Shepherd, F., Smith, C., Gandara, D., Johnson, D., Green, M. and Miller, R.: Phase III Study of Concurrent Chemotherapy and Full Course Radiotherapy (CT/RT) Versus CT/RT Induction Followed by Surgical Resection for Stage IIIA (pN2) Non-Small Cell Lung Cancer (NSCLC): First Outcome Analysis of North American Intergroup trial 0139. International Assoc Study of Lung Cancer (IASLC), Vancouver, British Columbia, Lung Cancer Meeting Booklet, pg. 14, Abs. #PL-4, 2003. |
9309 |
lung/nsc
surg |
|
| LUNG/nsc |
Choy, H., Swann, S., Sandler, A., Whipple, G., Demas, W. and Ettinger, D.: A Phase I Trial of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Concurrent Radiation Therapy Followed by Consolidative Gemcitabine and Carboplatin for Inoperable Stage III Non-Small Cell Lung Cancer: An RTOG Study. International Assoc Study of Lung Cancer (IASLC), Vancouver, British Columbia, Lung Cancer Meeting Booklet, pg. 62, Abs. #P-171, 2003. |
0017 |
lung/nsc
chemo/rt |
|
| LUNG/nsc |
Emami, B., Mirkovic, N., Scott, C., Byhardt, R., Graham, M. V., Andras, E. J., John, M., Herskovic, A., Urtasun, R. C., Asbell, S. O., Perez, C. A. and Cox, J.: The Impact of Regional Nodal Radiotherapy (Dose/Volume) On Regional Progression and Survival in Unresectable Non-Small Cell Lung Cancer: An Analysis of RTOG Data. Lung Cancer, 41 (2):207-214, 2003. |
7811, 7917, 8311, 8407 |
lung/nsc
td |
|
| LUNG/nsc |
Movsas, B., Scott, C., Langer, C., Werner-Wasik, M., Nicolaou, N., Komaki, R., Machtay, M., Smith, C., Axelrod, R. and Byhardt, R.: Phase III Study of Amifostine in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Chemotherapy & Hyperfractionated Radiation (Chemo/Hfxrt): Radiation Therapy Oncology Group (RTOG) 98-01. Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 636, Abs. #2559, 2003. |
9801 |
lung/nsc
protect |
|
| LUNG/nsc |
Machtay, M., Swann, S., Komaki, R., Langer, C., Byhardt, R., Sause, W. and Curran Jr, W.: Cisplatin Dose Delivery and Survival in Concurrent Chemoradiation for Stage III NSCLC: An RTOG Secondary Analysis. International Assoc Study of Lung Cancer (IASLC), Vancouver, British Columbia, Lung Cancer Meeting Booklet, pg. 45, Abs. #0-265, 2003. |
9106, 9204, 9410 |
lung/nsc
chemo |
|
| Lung/sc |
Komaki, R., Swann, S., Ettinger, D., Glisson, B., Sandler, A., Movsas, B. and Byhardt, R.: Phase I Dose-Escalation Study of Thoracic Irradiation with Concurrent Chemotherapy for Patients with Limited Small Cell Lung Cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) Protocol 97-12. Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 631, Abs. #2539, 2003. |
9712 |
lung/sc
chemo |
|
| Lung/nsc |
Albain, K. S., Scott, C., Rusch, V., Turrisi, A. T., Shepherd, F., Smith, C., Gandara, D., Johnson, D., Green, M. and Miller, R.: Phase III Comparison of Concurrent Chemotherapy Plus Radiotherapy (CT/RT) and CT/RT Followed by Surgical Resection for Stage IIIA(Pn2) Non-Small Cell Lung Cancer (NSCLC): Initial Results From Intergroup Trial 0139 (RTOG 93-09). Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 621, Abs. #2497, 2003. |
9309 |
lung/nsc
surg |
|
| Lung/nsc |
Curran, W., Scott, C., Langer, C., Komaki, R., Lee, J., Hauser, S., Movsas, B., Wasserman, T., Sause, W. and Cox, J.: Long-Term Benefit is Observed in a Phase III Comparison of Sequential vs Concurrent Chemo-Radiation for Patients with Unresected Stage III NSCLC: RTOG 94-10. Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 621, Abs. #2499, 2003. |
9410 |
lung/nsc
chemo |
|
| Lung/nsc |
Wakelee, H., Stephenson, P., Keller, S., Wagner, H., Herskovic , A., Komaki, R., Marks, R., Perry, M., Livingston, R. and Johnson, D.: Post-Operative Radiotherapy (PORT) or Chemoradiotherapy (CPORT) Following Resection of Stages II and IIIa Non-Small Cell Lung Cancer (NSCLC) Leads to Higher Than Expected Risk of Death From Intercurrent Disease (DID). Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 633, Abs. #2545, 2003. |
9105 |
lung/nsc
surg |
|
| Lung/nsc |
Keller, S., Vangel, M., Adak, S., Wagner, H., Herskovic, A., Komaki, R., Perry, M., Marks, R., Livingston, R. and Johnson, D.: The Influence of Gender On Survival and Tumor Recurrence Following Adjuvant Therapy of Completely Resected Stages II and IIIa Non-Small Cell Lung Cancer. Lung Cancer, 37 303-309, 2002. |
9105 |
surg |
|
| Lung/nsc |
Johnstone, D., Byhardt, R., Ettinger, D. and Scott, C.: Phase III Study Comparing Chemotherapy and Radiotherapy with Preoperative Chemotherapy and Surgical Resection in Patients with Non-Small-Cell Lung Cancer with Spread to Mediastinal Lymph Nodes (N2); Final Report of RTOG 89-01. Int J Radiat Onco Biol Phys, 54 (2):365-369, 2002. |
8901 |
surg |
|
| Lung/nsc |
Komaki, R., Seiferheld, W., Ettinger, D., Lee, J., Movsas, B. and Sause, W.: Randomized Phase II Chemotherapy and Radiotherapy Trial for Patients with Locally Advanced Inoperable Non-Small-Cell Lung Cancer: Long-Term Follow-Up of RTOG 92-04. Int J Radiat Onco Biol Phys, 53 (3):548-557, 2002. |
9204 |
td |
|
| Lung/nsc |
Fleishman, S. B., Dresler, C., Herndon II, J. E., Kornblith, A. B., Kernstine, K., Perry, M., Jablons, D., Sugarbaker, D., Haasler, G. T. and Daniel, T. M.: Quality Of Life (QOL) Advantage Of Sclerosis For Malignant Pleural Effusion (MPE) Via Talc Thoracoscopy Over Chest Tube Infusion Of Talc Slurry: A Cancer And Leukemia Group B Study. Proc of Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [21] pg. 355a, Abs. #1418, 2002. |
9511 |
QOL |
|
| Lung/nsc |
Movsas, B.: Exploring the Role of the Radioprotector Amifostine in Locally Advanced Non-Small Cell Lung Cancer: Radiation Therapy Oncology Group Trial 98-01. Sem in Rad Oncol, 12 (1 (Suppl 1)):40-45, 2002. |
9801 |
protect |
|
| Lung/nsc |
Firat, S., Byardt, R. and Gore, E.: Comorbidity and Karnofksy Performance Score are Independent Prognostic Factors in Stage III Non-Small-Cell Lung Cancer: An Institutional Analysis of Patients Treated on Four RTOG Studies. Int J Radiat Onco Biol Phys, 54 (2):357-364, 2002. |
8808, 8407, 8403, 8311 |
chemo |
|
| Lung/nsc |
Bradley, J., Scott, C., Paris, K., Demas, W., Machtay, M., Komaki, R., Movsas, B., Rubin, P. and Sause, W.: A Phase III Comparison of Radiation Therapy With or Without Recombinant b-Interferon for Poor-Risk Patients with Locally Advanced Non-Small Cell Lung Cancer (RTOG 93-04). Int J Radiat Onco Biol Phys, 52 (5):1173-1179, 2002. |
9304 |
chemmod |
|
| Lung/nsc |
Werner-Wasik, M., Scott, C., Curran Jr, W. and Byhardt, R.: Correlation Between Acute Esophagitis And Late Pneumonitis In Patients (Pts) With Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Receiving Concurrent Thoracic Radiotherapy (RT) And Chemotherapy: A Multivariate Analysis Of The Radiation Therapy Oncology Group (RTOG) Database. Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 299a, Abs. #1191, 2002. |
9410, 9204, 9015 |
td |
|
| Lung/nsc |
Langer, C., Hsu, C., Curran, W., Komaki, R., Lee, J., Byhardt, R. and Sause, W.: Elderly Patients (Pts) With Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Benefit From Combined Modality Therapy: Secondary Analysis Of Radiation Therapy Oncology Group (RTOG) 94-10. Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 299a, Abs. #1193, 2002. |
9410 |
chemo |
|
| Lung/nsc |
Lee, J. S., Scott, C., Komaki, R., Ettinger, D. and Sause, W.: Impact of Institutional Experience on Survival Outcome of Patients Undergoing Combined Chemoradiation Therapy for Inoperable Non-Small Cell Lung Cancer. Int J Radiat Onco Biol Phys, 52 (2):362-370, 2002. |
9106, 9204 |
chemo |
|
| Lung/nsc |
Keller, S., Vangel, M., Wagner, H., Schiller, J., Herskovic, A., Komaki, R., Brooks, B., Perry, M., Marks, R., Livingston, R. and Johnson, D.: Second Primary Tumors Following Adjuvant Therapy Of Resected Stages II And IIa Non-Small Cell Lung Cancer (NSCLC). Proceeding from Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 21: pg. 301a, Abs. #1202, 2002. |
9105 |
surg |
|
| Lung/nsc |
Lee, J. S., Scott, C., Komaki, R., Ettinger, D. and Sause, W.: Impact of Institutional Experience on Survival Outcome of Patients Undergoing Combined Chemoradiation Therapy for Inoperable Non-Small Cell Lung Cancer. Int J Radiat Onco Biol Phys, 52(2):362-370, 2002. |
9106, 9204 |
chemo |
|
| Lung/nsc |
Curran, W., Scott, C., Bonomi, P., Choy, H., Travis, P., Haluschak, J. and Belani, C.: Initial Report of Locally Advanced Multimodality Protocol (LAMP): ACR 427: A Randomized 3-Arm Phase II Study of Paclitaxel (T), Carboplatin (C), and Thoracic Radiation (TRT) for Patients with Stage III Non-Small Cell Lung Cancer (NSCLC). Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20(pg. 312a, Abs. #1244, 2001. |
---- |
rt |
|
| Lung/nsc |
Ettinger, D., Hsu, C., Bradley, J., Pilepich, M., Machtay, M., Komaki, R., Atkins, J., Curran, W. and Graham, M.: Phase II Study of Postoperative Adjuvant Therapy In Patients With Completely Resected Stage II And IIIA Non-Small Cell Lung Cancer (RTOG 97-05). Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 23-24, Abs. #36, 2001. |
9705 |
chemo |
|
| Lung/nsc |
Langer, C., Hsu, C., Curran, W., Komaki, R., Lee, J., Byhardt, R. and Sause, W.: Do Elderly Patients (Pts) with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Benefit from Combined Modality Therapy? A Secondary Analysis Of RTOG 94-10. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 20-21, Abs. #31, 2001. |
9410 |
chemo |
|
| Lung/nsc |
Graham, M., Winter, K., Purdy, J., Bradley, J., Komaki, R., Halperin, R., Ryu, J., Harms, W. B. and Emami, B.: Preliminary Results of A Radiation Therapy Oncology Group Trial (RTOG 93-11), A Dose Escalation Study Using 3D Conformal Radiation Therapy In Patients With Inoperable Non-Small Cell Lung Cancer. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 19-20, Abs. #29, 2001. |
9311 |
3D |
|
| Lung/nsc |
Machtay, M., Hsu, C., Komaki, R., Sause, W., Lee, J., Langer, C., Byhardt, R. and Curran, W.: Concurrent Chemoradiation for Locally Advanced NSCLC in The RTOG Experience: Effect of Overall Treatment Time. Proc of Am Soc Ther Rad Oncol (ASTRO), San Francisco, CA, Int J Radiat Oncol Biol Phys, 51(3, Suppl 1): pg. 348, Abs. #2236, 2001. |
9106, 9204, 9410 |
chemo |
|
| Lung/sc |
Glisson, B., Scott, C., Komaki, R., Movsas, B. and Wagner, H.: Cisplatin, Ifosfamide, Oral Etoposide and Concurrent Accelerated Hyperfactionated Thoracic Radiation for Patients with Limited Small-Cell Lung Carcinioma: Results of RTOG 93-12. J Clin Oncol, 18(16):2990-2995, 2000. |
9312 |
chemo |
|
| Lung/nsc |
Lippman, S. M., Lee, J. J., Karp, D. D., Vokes, E. E., Benner, S. E., Goodman, G. E., Khuri, F. R., Marks, R., Winn, R. J., Williams, B., Perez, C., Lotan, R., Roth, J. A. and Hong, W. K.: Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer. J Natl Can Inst, 93(8):605-618, 2001. |
9101 |
path |
|
| Lung/nsc |
Movsas, B., Scott, C., Curran Jr, W., Byardt, R. and Langer, C.: A Quality-Adjusted Time Without Symptoms or Toxicity (QTWiST) Analysis of Radiation Therapy Oncology Group (RTOG) 94-10. Proc Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #1247, 313a, 2001. |
9410 |
chemo |
|
| Lung/nsc |
Schiller, J., Adak, S., Foins, B., Keller, S., Fry, W., Livingston, R., Wolf, B., Jett, J., Kohman, L., Johnson, D. and Hammond, E.: Lack of Prognostic significance of p53 and K-RAS Mutations in Primary Resected Non-Small Cell Lung Cancer on E4592: A Lobaratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy. J Clin Oncol, 19(2):448-457, 2001. |
9409 |
surg |
|
| Lung/nsc |
Keller, S., Adak, S., Wagner, H., Herskovic, A., Komaki, R., Brooks, B., Perry, M., Livingston, R. and Johnson, D.: A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIA Non-Small Cell Lung Cancer. New Eng J Med, 343(17):1217-1222, 2000. |
9105 |
surg |
|
| Lung/nsc |
Komaki, R., Seiferheld, W., Curran, W., Langer, C., Lee, J., Hauser, S., Movsas, B., Wasserman, T., Russell, A., Byhardt, R., Sause, W. and Cox, J.: Sequential vs. Concurrent Chemotherapy and Radiation Therapy for Inoperable Non-Small Cell Lung Cancer (NSCLC): Analysis of Failures in a Phase III Study (RTOG 9410). Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 113, Abs. #5, 2000. |
9410 |
chemo |
|
| Lung/nsc |
Movsas, B., Scott, C., Sause, W., Byhardt, R., Komaki, R., Cox, J., Johnson, D., Lawton, C., Dar, A., Wasserman, T., Roach, M., Lee, J. and Andras, E.: Age Dramatically Impacts on the Quality-Adjusted Time without Symptoms of Toxicity (Q-Twist) in Locally Advanced Non-Small Cell Lung Cancer--A RTOG Analysis. Proc of Am Soc Ther Rad Oncol (ASTRO), Boston, MA, Int J Radiat Oncol Biol Phys, [48], pg. 157-158, Abs. #92, 2000. |
8311, 8804, 8808, 9015 |
QOL |
|
| Lung/nsc |
Werner-Wasik, M., Scott, C., Cox, J., Sause, W., Byhardt, R., Asbell, S., Russell, A., Komaki, R. and Lee, J.: Recursive Partitioning Analysis of 1999 Radiation Therapy Oncology Group (RTOG) Patients with Locally-Advanced Non-Small-Cell Lung Cancer (LA-NSCLC): Identification of Five Groups with Different Survival. Int J Radiat Oncol Biol Phys, 48(5):1475-1482, 2000. |
8311, 8321, 8403, 8407, 8804, 8808, 9015, 9106, 9204 |
chemo |
|
| Lung/nsc |
Curran, W., Scott, C., Langer, C., Komaki, R., Lee, J., Hauser, S., Movsas, B., Wasserman, T., Russell, A., Byhardt, R., Sause, W. and Cox, J.: Phase III Comparison of Sequential vs. Concurrent Chemoradiation for Pts. with Unresected Stage III Non-Small Cell Lung Cancer (NSCLC): Initial Report of Radiaton Therapy Oncology Group (RTOG) 9410. 9th World Conf on Lung Cancer (IASLC), Toyko, Japan, pg. Abs. 2000. |
9410 |
chemo |
|
| Lung/nsc |
Graham, M., Paulus, R., Wasserman, T., Pilepich, M., Machtay, M., Komaki, R., Akins, J. and Curran, W.: Preliminary Results of a Radiation Therapy Oncology Group (RTOG) trial 97-05, A Phase II Study of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II and Stage IIIA Non-Small Cell Lung Cancer. 9th World Conf on Lung Cancer (IASLC), Tokyo, Japan, pg. Abs. 2000. |
9705 |
surg |
|
| Lung/nsc |
Komaki, R., Seiferheld, W., Ettinger, D., Lee, J., Movsas, B. and Sause, W.: Randomized Chemoradiation for Patients with Locally Advanced Inoperable Non-Small Cell Lung Cancer (NSCLC): Long-Term Follow-up of RTOG 92-04. 9th World Conf on Lung Cancer (IASLC), Tokyo, Japan, pg. Abs. 2000. |
9204 |
chemo |
|
| Lung/nsc |
Konski, A., Scott, C., Movsas, B., Johnson, D., Cox, J., Sause, W., Byhardt, R. and Komaki, R.: Cost-Utility Analysis of Various Treatments for Non-Small Cell Carcinoma of the Lung. EORT Conference, Brussels, Belgium, European J Cancer, pg. Abs. 2000. |
8311, 8804, 8808, 9015, (multi) |
ECON |
|
| Lung/nsc |
Langer, C., Scott, C., Byhardt, R., Movsas, B., Sause, W., Komaki, R., Lee, J. and Curran, W.: Effect of Advanced Age on Outcome in Radiation Therapy Oncology Group Studies of Locally Advanced NSCLC. 9th World Conf on Lung Cancer (IASLC), Tokyo, Japan, pg. Abs. 2000. |
|
specpop |
|
| Lung/nsc |
Sause, W., Scott, C., Byhardt, R., Komaki, R., Lee, J., Curran, W., Movsas, B. and Ettinger, D.: Combined Chemotherapy Radiation Therapy Treatment in Unresectable Non-Small Cell Lung Cancer Radiation Therapy Oncology Group (RTOG) Experience. 9th World Conf on Lung Cancer (IASLC), Toyko, Japan, pg. Abs. 2000. |
8804,8808, 9015, 9106, 9204, 9410, 9801 |
chemo/rt |
|
| Lung/sc |
Ettinger, D., Seiferheld, W., Abrams, R., Fontanesi, J., Machtay, M., Curran, W. and Byhardt, R.: Cisplatin (P) , Etoposide (E), Pacitaxel (T) and Concurrent Hyperfractionated Thoracic Radiotherapy (TRT) for Patients (Pts) with Limited Disease (LD) Small Cell Lung Cancer (SCLC): Preliminary Results of RTOG 96-09. Proc of Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [19], pg. 490a, Abs. #1917, 2000. |
9609 |
chemo |
|
| Lung/nsc |
Movsas, B., Scott, C., Sause, W., Byhardt, R., Komaki, R., Cox, J., Johnson, D., Lawton, C., Dar, A., Wasserman, T., Roach, M., Lee, J. and Andras, E.: A Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWIST) Analysis of the Radiation Therapy Oncology Group (RTOG) Chemoradiation Studies for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC). American Radium Society, London, England, American Radium Society Proceedings, [April 1-5, 2000], pg. 31-32, Abs. #50, 2000. |
8311,8804,8808,9015 |
QOL |
|
| Lung/nsc |
Sause, W., Kolesar, P., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, E., Curran, W., Byhardt, R. and Fisher, B.: Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588. Chest, 117(2):358-364, 2000. |
8808 |
chemo |
|
| Lung/nsc |
Herskovic, A., Scott, C., Demas, W., Gaspar, L. and Trotti, A.: Accelerated Hyperfractionation for Bronchogenic Cancer - RTOG 92-05. Am J Clin Oncol, 23(2):207-212, 2000. |
9205 |
td |
|
| Lung/nsc |
Curran, W., Scott, C., Langer, C., Komaki, R., Lee, J., Hauser, S., Movsas, B., Wasserman, T., Russell, A., Byhardt, R., Sause, W. and Cox, J.: Phase III Comparison of Sequential vs. Concurrent Chemo Radiation for Pts. with Unresected Stage III Non-Small Cell Lung Cancer (NSCLC): Initial Report of Radiation Therapy Oncology Group (RTOG) 94-10. Proc of Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [19], pg. 484a, Abs. #1891, 2000. |
9410 |
chemo |
|
| Lung/sc |
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S. and Johnson, D.: Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide. New Eng J Med, 340(4):265-271, 1999. |
8815 |
chemo/td |
|
| Lung/nsc |
Movsas, B., Scott, C., Sause, W., Byhardt, R., Komaki, R., Cox, J., Johnson, D., Lawton, C., Dar, A., Wasserman, T., Roach, M., Lee, J. and Andras, E.: The Benefit of Treatment Intensification is Age and Histology-Dependent in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC): A Quality-Adjusted Survival Analysis of Radiation Therapy Oncology Group (RTOG) Chemo-Radiation Studies. Int J Radiat Oncol Biol Phys, 45(5):1143-1149, 1999. |
8808, 8804, 8311, 9015,9106,9204 |
QOL |
|
| Lung/nsc |
McDonald, S., Scott, C., Rubin, P., Paris, K., Demas, W., Machtay, M., Komaki, R. and Mosvas, B.: A Phase III Study Evaluating the Efficacy of Conventional Radiation Therapy with or without Recombinant -Interferon for Patients with Locally Advanced Non-Small Cell Lung Cancer and Poor Prognostic Characteristics (RTOG 93-04). Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. 379-380, Abs. #2197, 1999. |
9304 |
chemmod |
|
| Lung/nsc |
Keller, S., Adak, S., Wagner, H., Herskovic, A., Komaki, R., Brooks, B., Perry, M., Livingston, R. and Johnson, D.: Randomized Prospective Comparison Of Adjuvant Mediastinal Radiation (RT) With or Without Concurrent Chemotherapy With Cisplatin And Etoposide (PE) For Patients With Completely Resected 51-3N1-2M0 Non-Small Cell Lung Cancer (NSCLC): US Lung Intergroup Trial 0115. Proc Am Soc Thera Rad Oncol (ASTRO), San Antonio, TX, Int J Radiat Oncol Biol Phys, [45], pg. Abs. 1999. |
9105 |
surg |
|
| Lung/nsc |
Machtay, M., Seiferheld, W., Komaki, R., Cox, J., Sause, W. and Byhardt, R.: Is Prolonged Survival Possible for Patients with Supraclavicular Node Metastases in NSCLC Treated with Chemoradiotherapy? Analysis of the RTOG Experience. Int J Radiat Oncol Biol Phys, 44(4):847-853, 1999. |
8311, 8804, 8808, 9015, 9106, 9204 |
QA |
|
| Lung/nsc |
Albain, K., Rusch, V., Turrisi, A., Scott, C., Byhardt, R. and Curran, W.: Interim Update of the National Cancer Institute High Priority North American Intergroup Trial 0139 (RTOG 9309) for Stage IIIA (N2) Non-Small Cell Lung Cancer: A Phase III Comparison of Concurrent Chemotherapy plus Standard Radiotherapy versus Concurrent Chemotherapy plus Radiotherapy Followed by Surgical Resection. Perugia International Conf IV, pg. Abs. 1999. |
9309 |
chemo |
|
| Lung/sc |
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S. and Johnson, D.: Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide. New Eng J Med, 340(4):265-271, 1999. |
8815 |
chemo/td |
|
| Lung/nsc |
Lee, J., Scott, C., Komaki, R., Ettinger, D. and Sause, W.: Effects of the Number of Patients Treated Per Institution on the Outcome of Therapy in Patients with Locally-Advanced Inoperable Non-Small Cell Lung Cancer: RTOG 91-06 and RTOG 92-04. Proc of Am Soc Clin Oncol (ASCO), Atlanta, GA, J Clin Oncol, [18], pg. 459a, Abs. #1773, 1999. |
9106, 9204 |
chemo |
|
| Lung/nsc |
Keller, S., Adak, S., Wagner, H., Herskovic, A., Brooks, B., Perry, M., Livingston, R. and Johnson, D.: Prospective Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stages II and IIIa Non-Small Cell Lung Cancer: An Intergroup Trial (E3590). Proc of Am Soc Clin Oncol (ASCO), Atlanta, GA, J Clin Oncol, [18], pg. 465a, Abs. #1793, 1999. |
9105 |
surg |
|
| Lung/nsc |
Schiller, J., Adak, S., Foins, B., Keller, S., Fry, W., Livingston, R., Wolf, B., Jett, J., Kohman, L., Johnson, D. and Hammond, E.: Prognostic significance of p53 and K-RAS Mutations in Primary Resected Non-Small Cell Lung Cancer: Preliminary Results from a Prospective Randomized Trial of Postoperative Adjuvant Therapy (Intergroup Trial 0115). Proc of Am Soc Clin Oncol (ASCO), Atlanta, GA, J Clin Oncol, [18], pg. 464a, Abs. #1789, 1999. |
9409 |
surg |
|
| Lung/nsc |
Werner-Wasik, M., Scott, C., Graham, M., Smith, C., Byhardt, R., Roach, M. and Andras, E.: Interfraction Interval Does Not Affect Survival of Patients with Non-Small Cell Lung Cancer Treated with Chemotherapy and/or Hyperfractionated Radiotherapy: A Multivariate Analysis of 1076 RTOG Patients. Int J Radiat Oncol Biol Phys, 44(2):327-331, 1999. |
8311, 8808, 9015, 9106 |
td |
|
| Lung/nsc |
Cox, J., Scott, C., Byhardt, R., Emami, B., Russell, A., Fu, K., Parliament, M., Komaki, R. and Gaspar, L.: Addition of Chemotherapy to Radiation Therapy Alters Failure Patterns by Cell Type Within Non-Small Cell Carcinoma of Lung (NSCCL): Analysis of Radiation Therapy Oncology Group (RTOG) Trials. Int J Radiat Oncol Biol Phys, 43(3):505-509, 1999. |
8311, 8321, 8407, 8808, 9015, 9106, 9204 |
td |
|
| Lung/nsc |
Komaki, R., Scott, C., Byhardt, R., Emami, B., Asbell, S., Russell, A., Roach, M., Parliament, M. and Gaspar, L.: Failure Patterns by Prognostic Group Determined by Recursive Partitioning Analysis (RPA) of 1,547 on Four Radiation Therapy Oncology Group (RTOG) Studies in Operable Non-Small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys, 42(2):263-267, 1998. |
8311, 8321, 8403, 8407 |
td |
|
| Lung/nsc |
Cox, J., Scott, C. B., Smith, C., Phillips, T. L., Emami, B., Byhardt, R. W., Slater, J. M., Asbell, S. O. and Hartsell, W. F.: Dose Escalation for Non-Small Cell Carcinoma of the Lung before 3D Conformal Radiation Therapy: Long-Term Observations of Normal Tissues from RTOG Protocol 83-11. In Treatment Optimization for Lung Cancer: From Classical to Innovative Procedures ed.) Elsevier, Paris, pg. 151-156, 1998. (Book section) |
|
QOL |
|
| Lung/nsc |
Movsas, B., Scott, C., Sause, W., Byhardt, R., Komaki, R., Cox, J., Johnson, D., Lawton, C., Dar, A., Wasserman, T., Roach, M., Lee, J. and Andras, E.: The Benefit of Treatment Intensification is Age and Histology-Dependent in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC): A Quality-Adjusted Survival Analysis of Radiation Therapy Oncology Group (RTOG) Chemo-Radiation Studies. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 203, Abs. #158, 1998. |
|
QOL |
|
| Lung/nsc |
Machtay, M., Seiferheld, W., Cox, J., Komaki, R., Byhardt, R. and Sause, W.: Are Patients with Supraclavicular Node Metastases in Non-Small Cell Lung Cancer (NSCLC) Curable with Chemoradiotherapy? An Analysis of the RTOG Experience. Proc Am Soc Thera Rad Oncol (ASTRO), Phoenix, AZ, Int J Radiat Oncol Biol Phys, [42], pg. 168, Abs. #87, 1998. |
|
chemo |
|
| Lung/nsc |
Hartsell, W., Scott, C., Dundas, G., Mohiuddin, M., Meredith, R. and Rubin, P.: Correlation of Pulmonary Function Tests (PFTs), Respiratory Symptoms and Baseline Dyspnea Index in Patients with Lung Cancer: Analysis of RTOG 91-03. Proceeding from Int Soc Qual of Life Research (ISOQOL), Baltimore, MD, Quality of Life Research, [7], pg. 604, Abs. 1998. |
|
QOL |
|
| Lung/nsc |
Orton, C. G., Chungbin, S., Klein, E. E., Gillin, M. T., Schultheiss, T. and Sause, W. T.: Study of Lung Density Corrections in a Clinical Trial RTOG 88-08. Int J Radiat Oncol Biol Phys, 41(4):787-794, 1998. |
|
QA/td |
|
| Lung/sc |
Glisson, B., Scott, C., Komaki, R., Movsas, B. and Wagner, H.: Cisplatin (P), Ifosfamide (I), Prolonged Oral Etoposide (E) (PIE), and Concurrent Accelerated Hyperfractionated Thoracic Radiotherapy (TRT) for Patients with Limited Small Cell Lung Cancer (LSCLC): Results of RTOG 93-12. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 450a, Abs. #1733, 1998. |
|
medonc |
|
| Lung/nsc |
Sause, W., Kolesar, P., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, E., Curran, W., Byhardt, R. and Fisher, B.: Five-Year Results: Phase III Trial of Regionally Advanced Unresctable Non-Small Cell Lung Cancer, RTOG 8808, ECOG 4588, SWOG 8992. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 453a, Abs. #1743, 1998. |
|
chemo/td |
|
| Lung/nsc |
Werner-Wasik, M., Scott, C., Cox, J., Sause, W., Byhardt, R., Asbell, S., Russell, A., Komaki, R. and Lee, J.: Recursive Partitioning Analysis of 1999 Radiation Therapy Oncology Group (RTOG) Patients with Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): Identificatin of Five Groups with Different Survival. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 460a, Abs. #1771, 1998. |
|
|
|
| Lung/nsc |
Curran, W. J. and Wasik-Werner, M.: Issues in Nonoperative Management of Locally Advanced Non Small Cell Lung Cancer. Oncology, 12(1 [Suppl 2]):60-66, 1998. |
|
|
|
| Lung/nsc |
Werner-Wasik, M. and Curran, W. J.: Optimizing Nonoperative Approaches to Locally Advanced Non-Small Cell Lung Cancer. Advances in Oncology, 13(4):10-16, 1998. |
|
|
|
| Lung/nsc |
Lippman, S., Lee, J., Karp, D., Vokes, E., Benner, S., Goodman, G., Kardinal, C., Winn, R., Roth, J. and Hong, W.: Phase III Intergroup Trial of 13-Cis-Retinoic Acid to Prevent Second Primary Tumors in Stage 1 Non-Small Cell Lung Cancer (NSCLC): Interim Report of NCI #191-0001. Proc of Am Soc Clin Oncol (ASCO), Los Angeles, CA, J Clin Oncol, [17], pg. 456a, Abs. #1753, 1998. |
|
|
|
| Lung/sc |
Komaki, R., Scott, C. B., Sause, W. T., Johnson, D. H., Taylor IV, S., Lee, J., Emami, B., Byhardt, R. W., Curran, W. J., Dar, A. and Cox, J. D.: Induction Cisplatin/Vinblastine and Irradiation vs. Irradiation in Unresectable Squamouis Cell Lung Cancer: Failure Patterns by Cell Type in RTOG 88-08/ECOG 4588. Int J Radiat Oncol Biol Phys, 39(3):537-544, 1997. |
|
chemo/td |
|
| Lung/nsc |
Curran, W. J.: A Phase III Trial Testing Chemoradiatin Sequencing in Stage III Non-Small Cell Lung Cancer. Current Clinical Trials in Thoracic Oncology, 1(2):5-7, Spring, 1997. |
|
chemo |
|
| Lung/nsc |
Komaki, R., Scott, C., Lee, J., Urtasun, R., Byhardt, R., Emami, B., Andras, E., Asbell, S., Rotman, M. and Cox, J.: Impact of Adding Concurrent Chemotherapy to Hyperfractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC): Comparison of RTOG 83-11 to RTOG 91-06. Am J Clin Oncol, 20(5):435-440, 1997. |
|
td/chemo |
|
| Lung/nsc |
Scott, C., Movsas, B., Sause, W., Byhardt, R., Komaki, R., Cox, J., Johnson, D., Lawton, C., Dar, A., Wasserman, T., Roach, M., Lee, J. and Andras, E.: Intensified Treatment Increases Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) at What Price? A Quality-Adjusted Survival Analysis of Radiatoin Therapy Oncology Group (RTOG) Chemo-Radiation Studies. Proc of ISOQOL, Vienna, Austria, Quality of Life Research, [6], pg. 718, Abs. #345, 1997. |
|
QOL |
|
| Lung/sc |
Glisson, B., Scott, C., Komaki, R., Movsas, B. and Wagner, H.: Cisplatin (P), Ifosfamide (I), Prolonged Oral Etoposide (E), and Concurrent accelerated Hyperfractionated Thoracic Radiotherapy (TRT) for Patients with Limited Small Cell Lung Cancer (LSCLC): Preliminary Results of a Phase II Trial. 8th World Conference on Lung Cancer, Dublin, Ireland, J Internl Assoc Lung Cancer, [18], pg. 89, Abs. #346, 1997. |
|
medonc |
|
| Lung/nsc |
Byhardt, R., Scott, C., Sause, W., Emami, B., Komaki, R., Fisher, B., Lee, J. and Lawton, C.: Toxicity in Five Radiation Therapy Oncology Group (RTOG) Trials of Sequential and/or Concurrent Chemotherapy (CT) Radiation Therapy (RT) for Locally Advanced Non-Small Cell Carcinoma of the Lung (NSCLC). 8th World Conference on Lung Cancer, Dublin, Ireland, J Internl Assoc Lung Cancer, [18], pg. 64, Abs. #244, 1997. |
|
chemo |
|
| Lung/nsc |
Byhardt, R., Kolesar, P., Sause, W., Emami, B., Komaki, R., Fisher, B., Lee, J. and Lawton, C.: Response Failure Patterns and Survival in Five Radiation Therapy Oncology Group (RTOG) Trials of Sequential and/or Concurrent Chemotherapy (CT) Radiation Therapy (RT) for Locally Advanced Non-Small Cell Carcinoma. 8th World Conference on Lung Cancer, Dublin, Ireland, J Internl Assoc Lung Cancer, [18], pg. 62, Abs. #238, 1997 |
|
chemo |
|
| Lung/nsc |
Byhardt, R., Scott, C., Sause, W., Emami, B., Komaki, R., Fisher, B., Lee, J. and Lawton, C.: Response, Toxicity, Failure Patterns and Survival in Five Radiation Therapy Oncology Group (RTOG) Trials of Sequential and/or Concurrent Chemotherapy (CT) and Radiation Therapy (RT) for Locally Advanced Non-Small Cell Carcinoma of the Lung (NSCLC). Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 195, Abs. #120, 1997. |
|
chemo |
|
| Lung/nsc |
Cox, J., Scott, C., Emami, B., Russell, A., Fu, K., Parliament, M., Komaki, R. and Gaspar, L.: Addition of Chemotherapy to Radiation Therapy Alters Failure Patterns by Cell Type Within Non-Small Cell Carcinoma of Lung (NSCCL): Analysis of Radiation Therapy Oncology Group (RTOG) Trials. 8th World Conference on Lung Cancer, Dublin, Ireland, J Internl Assoc Lung Cancer, [18], pg. 126, Abs. #491, 1997. |
|
td |
|
| Lung/nsc |
Ginsberg, R., Cox, J., Green, M., Bulzebruck, H., Grunenwald, D., Harper, P., Jett, J., LeChevalier, T., Mornex, F., Scott, C. and Rsuchiya, R.: Consensus Report: Staging Classification Committee. Lung Cancer, 17(Suppl (1)):S11-S13, 1997. |
|
epid |
|
| Lung/nsc |
Komaki, R., Scott, C., Ettinger, D., Lee, J., Fossella, F., Curran, W., Evans, R., Rubin, P. and Byhardt, R.: Randomized Study of Chemotherapy/Radiation Therapy Combinations for Favorable Patients with Locally Advanced Inoperable Non-Small Cell Lung Cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Int J Radiat Oncol Biol Phys, 38(1):149-155, 1997. |
|
td |
|
| Lung/nsc |
Komaki, R., Scott, C., Byhardt, R., Emami, B., Asbell, S., Russell, A., Roach, M., Urtasun, R. and Gaspar, L.: Failure Patterns by Prognostic Group as Determined by Recursive Partitioning Analysis (RPA) of 1,547 on Four Radiation Therapy Oncology Group Studies in Operable Non-Small Cell Lung Cancer (NSCLC). Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 196, Abs. #122, 1997. |
|
td |
|
| Lung/nsc |
Scott, C., Sause, W., Byhardt, R., Marcial, V., Pajak, T., Herskovic, A. and Cox, J.: Recursive Partitioning Analysis of 1,592 Patients on Four Radiation Therapy Oncology Group Studies in Inoperable Non-Small Cell Lung Cancer. Lung Cancer, 17(Suppl (1):S59-S74, 1997. |
|
meth |
|
| Lung/nsc |
Scott, C., Sause, W., Johnson, D., Dar, A., Wasserman, T., Rubin, P., Khandekar, J., Byhardt, R., Taylor, S. and McDonald, A.: Factors Which Influence Quality of Life in Patients with Non-Small Cell Lung Cancer (NSCLC): A Radiation Therapy Oncology Group (RTOG 89-01). Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 198, Abs. #126, 1997. |
|
QOL |
|
| Lung/nsc |
Werner-Wasik, M., Scott, C., Graham, M., Smith, C., Byhardt, R., Roach, M. and Andras, E.: Interfraction Interval Does Not Affect Survival of Patients with Non-Small Cell Lung Cancer Treated with Hyperfractionated Radiotherapy With/Without Chemotherapy: A Multivariate Analysis of 682 RTOG Patients. Proc Am Soc Thera Rad Oncol (ASTRO), Orlando, FL, Int J Radiat Oncol Biol Phys, [39], pg. 314, Abs. #2147, 1997. |
|
td |
|
| Lung |
Sause, W. T., Pajak, T., Cox, J. D., Asbell, S. O., Perez, C., Urtasun, R. C. and Roach III, M.: A Radiation Therapy Oncology Group Experience: Chemotherapy/Radiation Therapy of Lung Cancer. Lung Cancer, 9(S2):S61-S68, 1993. |
|
chemo |
|
| Lung |
Sause, W., Pajak, T., Emami, B., Byhardt, R., Herskovic, A. and Cox, J.: The Radiation Therapy Oncology Group Experience Altered Fractionation in Lung Cancer. Lung Cancer, 9:229-238, 1993. |
|
td |
|
| Lung |
Herskovic, A., Farnan, N., Demas, W., Gaspar, L. and Trotti, A.: Tolerance and Toxicity of T.I.D. Accelerated Hyperfractionation for Bronchogenic Cancer - RTOG 92-05. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):278, [2033], 1995. |
9205 |
td |
|
| Lung |
McDonald, S., Rubin, P., Phillips, T. L. and Marks, L. B.: Injury to the Lung from Cancer Therapy: Clinical Syndromes, Measurable Endpoints, and Potential Scoring Systems. Int J Radiat Oncol Biol Phys, 31(5):1187-1203, 1995. |
|
lateff |
|
| Lung |
Sause, W. T.: Combination Chemotherapy and Radiation Therapy in Lung Cancer. Semin Oncol, 21(3, Supple 6 (June)):72-78, 1994. |
|
chemo |
|
| Lung |
Sause, W. T.: Is a Nihilist Approach to Lung Cancer Still Justified? Int J Radiat Oncol Biol Phys, 27(3):747-748, 1993. |
|
other |
|
| Lung |
Russell, A., Pajak, T., Selim, H., Paradelo, J., Murray, K., Bansal, P., Cooper, J., Silverman, S. and Clement, J.: Prophylactic Cranial Irradiation for Lung Cancer Patients at High Risk for Development of Cerebral Metastasis: Results of a Prospective Randomized Trial Conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 21:637-643, 1991. |
8403 |
td |
|
| Lung |
Cox, J.: Altered Fractionation in Radiation Therapy. In Lung Cancer (Roth, J.A., Cox, J.D. and Hong, W.K., ed.) Blackwell Scientific Publications, Inc., Cambridge, MA, pg. 208-221, 1993. |
|
td |
|
| Lung/nsc |
Emami, B., Scott, C., Byhardt, R., Graham, M. V., Andras, E. J., John, M., Herskovic, A., Urtasun, R. C., Asbell, S. O., Perez, C. A. and Cox, J.: The Value of Regional Nodal Radiotherapy (Dose/Volume) in the Treatment of Unresectable Non-Small Cell Lung Cancer: An RTOG Analysis. Proc Am Soc Thera Radiol Oncol (ASTRO), Los Angeles, CA, Int J Radiat Oncol Biol Phys, 36 (1):209, [102], 1996. |
7811, 7917, 8311, 8407 |
td |
|
| Lung/nsc |
Curran, W.: New Strategies Involving Radiation Therapy for Patients with Non-Small Cell Lung Cancer. Chest, 107:3025-3055, 1995. |
|
meth |
|
| Lung/nsc |
Byhardt, R.: The Evolution of Radiation Therapy Oncology Group (RTOG) Protocols for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys, 32(5):1513-1525, 1995. |
|
admin |
|
| Lung/nsc |
Graham, M., Pajak, T., Herskovic, A., Emami, B. and Perez, C.: Phase I/II Study of Treatment of Locally Advanced (T3/T4) Non-Oat Cell Lung Cancer with Concomitant Boost Radiotherapy by the Radiation Therapy Oncology Group: Long-Term Results. Int J Radiat Oncol Biol Phys, 31(4):819-825, 1995. |
8312 |
td |
|
| Lung/nsc |
Cox, J., Pajak, T., Herskovic, A., Urtasun, R., Podolsky, W. and Seydel, H.: Five-year Survival After Hyperfractionated Radiation Therapy for Non-Small Cell Carcinoma of the Lung (NSCCL): Results of RTOG Protocol 81-08. Am J Clin Oncol (CCT), 14(4):280-284, 1991. |
8108 |
td |
|
| Lung/nsc |
Cox, J.: The Respective Roles of Radiation Therapy and Chemotherapy in Non-Small Cell Carcinoma of the Lung with Mediastinal But Not Distant Metastasis (N2M0). Lung Cancer, 7:65-69, 1991. |
|
chemo |
|
| Lung/nsc |
Cox, J., Azarnia, N., Byhardt, R., Shin, K., Emami, B. and Perez, C.: N2 (clinical) Non-Small Cell Carcinoma of the Lung: Prospective Trials of Radiation Therapy with Total Doses ≥ 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 20:7-12, 1991. |
8311 |
td |
|
| Lung/nsc |
Komaki, R., Scott, C., Lee, J., Urtasun, R., Byhardt, R., Emami, B., Andras, E., Asbell, S., Rotman, M. and Cox, J.: Increased Survival from Addition of Cisplatin and Oral Etoposide to Hyperfractionated Radiation Therapy (HFX) for Non-Small Cell Lung Cancer (NSCLC): Comparison of RTOG 91-06 to 83-11. ARS (95), Paris, France, Proceedings of the American Radium Society 78th Annual Meeting, April 29 - May 3 (meeting dates) 32, [65], 1995. |
9106, 8311 |
chemo/td |
|
| Lung/nsc |
Sause, W., Scott, C., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, B., Curran, W., Byhardt, R., Dar, A. R. and Turrisi, A.: RTOG 88-08/ECOG 4588, Preliminary Analysis of a Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer. Seventh World Conference on Lung Cancer, Colorado Springs, Colorado, Lung Cancer, 11, Supplement no. 1 (June 1994):179, [695], 1994. |
8808 |
chemo/td |
|
| Lung/nsc |
Komaki, R., Scott, C., Lee, J., Fossella, F., Dundas, G., McDonald, S., Palmer, M., Curran, W. and Byhardt, R.: Phase I/II Study of Combined Chemoradiation Therapy with Cisplatin Plus Oral Etoposide for Patients with Locally Advanced Inoperable Non-Small Cell Lung Cancer (NSCLC): RTOG 91-06. Seventh World Conference on Lung Cancer, Colorado Springs, Colorado, Lung Cancer, Volume 11 (Supplement 1):178, [690], 1994. |
9106 |
chemo |
|
| Lung/nsc |
Curran, W.: New Chemotherapy/Radiation Therapy Regimens May Improve Survival for Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer. COPE, Jan./Feb.):10-17, 1996. |
8804, 8808, 9015, 9016 |
|
|
| Lung/nsc |
Group, N. S. C. L. C. C.: Chemotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis Using Updated Data on Individual Patients From 52 Randomized Clinical Trials. BMJ, 311:899-909, 1995. |
|
stat/meth |
|
| Lung/nsc |
Komaki, R., Pajak, T., Byhardt, R., Emami, B., Asbell, S., Roach, M., Pedersen, J., Curran, W., Herskovic, A., Russell, A. and Cox, J.: Analysis of Early and Late Deaths on RTOG Non-Small Lung Carcinoma Trials vs. CALGB 8433. Proc Am Soc Thera Radiol Oncol (ASTRO), Int J Radiat Oncol Biol Phys, 21 (1):137, [44], 1991. |
|
other |
|
| Lung/nsc |
Sause, W., Scott, C., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, B., Curran, W., Byhardt, R. and Fisher, B.: RTOG 88-08/ECOG 4588, Preliminary Analysis of a Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer. Proc Am Soc Clin Oncol (ASCO), Dallas, TX, Proc Am Soc Clin Oncol, 13 (March):325, [1072], 1994. |
8808 |
chemo/td |
|
| Lung/nsc |
Curran, W., Cox, J., Azarnia, N., Byhardt, R., Shin, K., Emami, B., Phillips, T., Selim, H., Herskovic, A., Mohiuddin, M., Ager, P., Krisch, R., Doggett, R. and Pajak, T.: Comparison of the RTOG and AJCC Staging Systems Among Patients with Non-Small Cell Lung Cancer Receiving Hyperfractionated Radiation Therapy: A Report of the RTOG Protocol 83-11. Cancer, 68:509-516, 1991. |
8311 |
path |
|
| Lung/nsc |
Lee, J., Farnan, N., Komaki, R., Fossella, F., Dundas, G., McDonald, S., Palmer, M., Curran, W. and Byhardt, R.: Promising Outcome of Concurrent Chemoradiation Therapy with Oral VP-16 and Cisplatin for Locally Advanced Inoperable Non-Small Cell Lung Cancer. Proc Am Soc Clin Oncol (ASCO), Los Angeles, CA, Proc Am Soc Clin Oncol Thirty-First Annual Mtg, 14 (March 1995):354, [1077*], 1995. |
9106 |
chemo |
|
| Lung/nsc |
Cox, J., Pajak, T., Asbell, S., Russell, A., Pedersen, J., Byhardt, R., Emami, B. and Roach III, M.: Interruptions of High-Dose Radiation Therapy for Non-Small Cell Carcinoma of the Lung Decrease Long-Term Survival in Favorable Patients. Proc Am Soc Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 (1):195, [120], 1992. |
8311 |
td |
|
| Lung/nsc |
Wagner, H.: Rational Integration of Radiation and Chemotherapy in Patients with Unresectable Stage IIIA or IIIB NSCLC. Chest, 103(1 (Supplement)):35s-42s, 1993. |
|
chemo |
|
| Lung/nsc |
Lee, J., Scott, C., Komaki, R., Fossella, F., Dundas, G., McDonald, S., Palmer, M., Curran, W. and Byhardt, R.: Concurrent Chemoradiation Therapy with Oral VP-16 and Cisplatin for Locally Advanced Inoperable Non-Small Cell Lung Cancer (NSCLC): RTOG Protocol 91-06. Proc Am Soc Clin Oncol (ASCO), Dallas, Texas, Proc Am Soc Clin Oncol, 13 (March):363, [1222], 1994. |
9106 |
chemo/td |
|
| Lung/nsc |
Sause, W. T., Scott, C., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, B., Curran, W. J., Byhardt, R. W., Turrisi, A., Dar, A. R. and Cox, J. D.: RTOG 88-08/ECOG 4588: Preliminary Results of a Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer. J Natl Cancer Inst, 87(3):198-205, 1995. |
8808 |
chemo/td |
|
| Lung/nsc |
Komaki, R., Pajak, T. F., Byhardt, R. W., Emami, B., Asbell, S. O., Roach III, M., Pedersen, J. E., Curran, W. J., Lattin, P., Russell, A. H. and Cox, J. D.: Analysis of Early and Late Deaths on RTOG Non-Small Cell Carcinoma of the Lung Trials: Comparison with CALGB 8433. Lung Cancer, 10:189-197, 1993. |
|
meth |
|
| Lung/nsc |
Byhardt, R., Martin, L., Pajak, T., Shin, K., Emami, B. and Cox, J.: The Influence of Field Size and Other Treatment Factors on Pulmonary Toxicity Following Hyperfractionated Irradiation for Inoperable Non-Small Cell Lung Cancer (NSCLC). Proc Am Soc Thera Radiol Oncol (ASTRO), San Diego, Int J Radiat Oncol Biol Phys, 24 (1):194-195, [119], 1992. |
8311 |
td |
|
| Lung/nsc |
Byhardt, R., Scott, C., Ettinger, D., Curran, W., Doggett, R., Coughlin, C., Scarantino, C., Rotman, M. and Emami, B.: Concurrent Hyperfractionated Irradiation and Chemotherapy for Non-Small Cell Lung Cancer. Preliminary Report of a Phase I/II Radiation Therapy Oncology Group (RTOG) Trial. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, Am J Clin Oncol (CCT), 12 327, [1085], 1993. |
9015 |
td/chemo |
|
| Lung/nsc |
Komaki, R., Scott, C., Ettinger, D., Lee, J., Murphy, W., Curran, W., Evans, R., Rubin, P. and Byhardt, R.: Randomized Phase II Study of Chemotherapy/Radiation Therapy Combinations for Favorable Patients with Locally Advanced Inoperable Non-Small Cell Cancer: RTOG 9204. Am Soc Clin Oncol (ASCO), Philadelphia, PA, Proc Am Soc Clin Oncol (ASCO), 15 (March 1996):514, [1656], 1996. |
9204 |
td |
|
| Lung/nsc |
Sause, W. T., Scott, C., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Cox, J. D., Emami, B., Curran, W. J., Byhardt, R. W., Fisher, B. J., Dar, A. R. and Turrisi, A. T.: RTOG 88-08/ECOG 4588, Preliminary Analysis of a Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer with Minimum Three Year Follow-up. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):108, [109], 1995. |
8808 |
chemo/td |
|
| Lung/nsc |
Byhardt, R. W.: Can Interferon Beta Make the Radiation Therapy Team for Treatment of Non-Small Cell Lung Cancer? Int J Radiat Oncol Biol Phys, 27(3):753-756, 1993. |
|
BRM |
|
| Lung/nsc |
Curran, W. J., Scott, C. B., Komaki, R., Byhardt, R. W., Taylor, S., Emami, B., Langer, C. J., Dar, A. R., Cooper, J. S., Andras, E. J. and Sause, W. T.: Response to Induction Chemotherapy Does Not Predict For Long Term Survival Among Patients with Unresected Stage III Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Chemo-Radiation on RTOG 88-04 and 88-08. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):196, [111], 1995. |
8804, 8808 |
chemo/td |
|
| Lung/nsc |
Byhardt, R. W., Scott, C. B., Ettinger, D. S., Curran, W. J., Doggett, R. L. S., Coughlin, C., Scarantino, C., Rotman, M. and Emami, B.: Concurrent Hyperfractionated Irradiation and Chemotherapy for Non-Small Cell Lung Cancer. Preliminary Report of a Phase I/II Radiation Therapy Oncology Group (RTOG) Trial. Proc American Radium Society, Bermuda, Proceedings of the American Radium Society's 76th Annual Meeting, (April 22-26, 1994):25, [40], 1994. |
9015 |
td/chemo |
|
| Lung/nsc |
Byhardt, R. W., Pajak, T. F., Emami, B., Herskovic, A., Doggett, R. S. and Olson, L. A.: A Phase I/II Study to Evaluate Accelerated Fractionation Via Concomitant Boost for Squamous, Adeno, and Large Cell Carcinoma of the Lung: Report of Radiation Therapy Oncology Group 84-07. Int J Radiat Oncol Biol Phys, 26(3):459-468, 1993. |
8407 |
td |
|
| Lung/nsc |
Byhardt, R., Scott, C., Ettinger, D., Curran, W., Doggett, R., Coughlin, C., Scarantino, C., Rotman, M. and Emami, B.: Concurrent Hyperfractionated Irradiation and Chemotherapy for Unresectable Non-Small Cell Lung Cancer. Cancer, 75(No. 9):2337-2344, 1995. |
9015 |
td/chemo |
|
| Lung/nsc |
Byhardt, R. W., Martin, L., Pajak, T. F., Shin, K. H., Emami, B. and Cox, J. D.: The Influence of Field Size and Other Treatment Factors on Pulmonary Toxicity Following Hyperfractionated Irradiation for Inoperable Non-Small Cell Lung Cancer (NSCLC)-Analysis of a Radiation Therapy Oncology Group (RTOG) Protocol. Int J Radiat Oncol Biol Phys, 27(3):537-544, 1993. |
8311 |
td/QA |
|
| Lung/nsc |
Lee, J. S., Scott, C., Komaki, R., Fossella, F. V., Dundas, G. S., McDonald, S., Byhardt, R. W. and Curran, W. J.: Concurrent Chemoradiation Therapy with Oral Etoposide and Cisplatin for Locally Advanced Inoperable Non-Small Cell Lung Cancer: RTOG Protocol 91-06. J Clin Oncol, 14(4):1055-1064, 1996. |
9106 |
chemo/td |
|
| Lung/nsc |
Graham, M., Geitz, L., Byhardt, R., Asbell, S., Roach III, M., Urtasun, R., Curran Jr, W., Lattin, P., Russell, A. and Cox, J.: Comparison of Prognostic Factors and Survival Among Black Patients and White Patients Treated with Irradiation for Non-Small-Cell Lung Cancer. J Natl Cancer Inst, 84:1731-1735, 1992. |
|
specpop |
|
| Lung/nsc |
Cox, J., Sause, W., Byhardt, R., Komaki, R., Perez, C. A. and Pajak, T.: Dose Intensity of Radiation Therapy in Non-Small Cell Carcinoma of the Lung: A Review of RTOG Data and Strategies. Lung Cancer, 10 (Suppl. 1)(March 1994):S161-S166, 1994. |
|
td |
|
| Lung/nsc |
Cox, J. D., Pajak, T. F., Asbell, S., Russell, A. H., Pedersen, J., Byhardt, R. W., Emami, B. and Roach III, M.: Interruptions of High-Dose Radiation Therapy Decrease Long-Term Survival of Favorable Patients with Unresectable Non-Small Cell Carcinoma of the Lung: Analysis of 1244 Cases from 3 Radiation Therapy Oncology Group (RTOG) Trials. Int J Radiat Oncol Biol Phys, 27(3):493-498, 1993. |
8311, 8321, 8403 |
td/lateff |
|
| Lung/nsc |
Sause, W., Scott, C., Byhardt, R., Emami, B., Marcial, V. and Herskovic, A.: Recursive Partitioning Analysis of 1,592 Patients on Four RTOG Studies in Non-Small Cell Lung Cancer. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, 12 336, [1123], 1993. |
8311, 8321, 8403, 8407 |
stat/meth |
|
| Lung/nsc |
Sause, W., Scott, C., Taylor, S., Byhardt, R., B | |
